Indefinite Delivery Contract SPE2DB24D9315

This federal contract IDV awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is a single-award indefinite delivery contract valued up to $499,999,999 through December 31, 2025. The contract enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. Key categories of goods to be delivered under this contract include medications such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, antibiotics, surgical supplies, and contraceptive products. This IDV complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. As a woman-owned small business, DMS Pharmaceutical Group has been awarded this non-set-aside contract leveraging its specialized capabilities in pharmaceutical supply chain management and direct-to-government distribution to U.S. military healthcare facilities globally.